Abstract
As search for optimal therapy continues for endometriosis, aid of dietary supplements is gaining attention. Supplements can be used for their anti-inflammatory, anti-oxidant, anti-proliferative and immune modulatory charactheristics. We reviewed the literature, evaluated and synthesized effects of vitamin D, zinc, magnesium, omega 3, propolis, quercetin, curcumin, N-acetylcysteine, probiotics, resveratrol, alpha lipoic acid, vitamin C, vitamin E, selenium and epigallocatechin-3-gallate. Based on results of in vitro, animal and human studies, it might be safe to say that dietary supplements can be used as a complementary treatment for endometriosis. (www.actabiomedica.it)
Keywords: dietary supplements, complementary therapies, endometriosis
Introduction
Pathogenesis of endometriosis involves the interaction of endocrine, immunologic, proinflammatory, and proangiogenic processes, all discussed in detail throughout the literature (1). There are new theories in endometriosis on these issues, the immune cells, adhesion molecules, extracellular matrix metalloproteinase and pro-inflammatory cytokines activate/alter peritoneal microenvironment, creating the conditions for differentiation, adhesion, proliferation and survival of ectopic endometrial cells (2-5). Whether these factors are causal or merely represent a feature of the pathophysiological process measured years after symptom onset remains uncertain. When choosing treatment for endometriosis, it is crucial to consider the patient’s predominant symptoms and preferences, age, the side-effect profile of medications, and outcomes of possible surgery; as well as the extent and location of disease, previous treatment, and cost effectivity (6,7).
Pathophysiology of endometriosis is, even today, not yet clarified, and the search for optimal treatment continues. Non-steroidal anti-inflammatory drugs, combined estrogen-progestin therapy, aromatase inhibitors, progestins, and selective progesterone receptor modulators are the main treatment options in current practice.
Elaborate pathogenetic mechanisms of endometriosis challenge clinicians to address each and every one of them when it comes to treatment. While conventional medical and surgical therapies are essential, the aid of dietary supplements may result in a synergistic effect by their anti-inflammatory, anti-oxidant, anti-proliferative, and immune-modulatory characteristics. Current surgical and medical approaches to endometriosis are inefficient for a sizable proportion of women, besides, treatment can be associated with complications and morbidity (8). Although peritoneal superficial lesions and ovarian endometriomas represent the majority of endometriotic implants within the pelvis, deep infiltrating endometriosis and extrapelvic endometriosis are the most challenging conditions to face off. Despite sometimes medical therapy is enough to reduce symptoms and signs (9,10), in a large number of patients a complete eradication, with nerve-sparing and vascular sparing approach (11,12) is needed to restore the normal pelvic anatomy and its functions. Considering these, while the search for new treatment options continues, the therapeutic benefits of dietary supplements with or without conventional treatment are being investigated. Different types of supplements can be effective in various ways. In this review, we aimed to evaluate the efficacy of supplement use for the treatment of endometriosis, by compiling the most used and studied supplements.
Vitamin D
Vitamin D is a fat-soluble vitamin that is naturally present in fatty fish (salmon, tuna, and mackerel), liver, egg yolk, and cheese (13). Vitamin D in these foods is primarily in the form of vitamin D3 and its metabolite 25(OH)D3.
1,25-dihydroxyvitamin-D3 (vitamin D) has immune-modulating effects on cell differentiation and proliferation in all cell types. Vitamin D deficiency and endometriosis have long been associated with autoimmune diseases (14). Furthermore, vitamin D receptors and vitamin D metabolizing enzymes are found in the ovaries and endometrium of women with and without endometriosis, in addition to the different immune cells and it is likely that vitamin D acts in a local immunologic environment (15). Vitamin D increases anti-inflammatory cytokines (transforming growth factor (TGF-β), interleukin (IL)-4) and decreases pro-inflammatory cytokines (tumor necrosis factor (TNF)-α, IL-2, IL-6), suggesting that vitamin D may help to improve chronic inflammatory and autoimmune diseases (16).
Though the physiological effects of vitamin D indicate probable relevance in endometriosis treatment, literature is scared. Studies on experimental animal models showed decreasing IL-6 levels in the peritoneal fluid after vitamin D supplementation (17). A double-blind clinical trial by Almassinokiani et al. found no significant effect of vitamin D supplementation on dysmenorrhea and/or pelvic pain of patients who had surgical treatment for endometriosis (15). Also, retrospective studies of patients with surgically confirmed endometriosis have shown higher dietary intake of vitamin D is correlated with decreased risk (18). A recent meta-analysis about vitamin D status of patients with endometriosis has shown that women with endometriosis had lower vitamin D levels compared to controls, and a negative relationship between vitamin D levels and severity of endometriosis was observed, however, this study was focused on vitamin D status, not the effects of vitamin D supplementation (19).
Zinc
Zinc is an essential mineral that is naturally present in some foods such as oysters, crab, lobster, red meat, poultry, beans, nuts, and dairy products (20). Excessive accumulation, deficiency, or an imbalance of trace metals might interfere with cell functions, cell degeneration, and apoptosis or resulting in abnormal cell proliferation and malignant transformation (21). Antioxidant enzymes usually need various trace metals for catalysis, so the essential trace metals in the human body play a role in both the immune reactions and the protection against oxidative damage (22). Zinc is an intracellular signaling molecule and an anti-inflammatory agent that has an essential role in oxidative stress and immune functions; inhibits free radical production (23). Zinc deficiency may complicate the clinical features in many diseases, affect the immunological status, increase the generation of inflammatory cytokines, and increase oxidative stress.
These properties of zinc might have some remedial effects. There are no in vitro or animal studies in literature, regarding zinc levels or supplementation in endometriosis. Studies conducted in patients with rheumatoid arthritis have shown that low plasma zinc correlates negatively with levels of TNF-α and IL-1β (24), a result which also has importance when endometriosis pathophysiology kept in mind. Many studies argued this relation, finding lower zinc levels were seen in women with endometriosis (25,26). In addition, a study suggested that zinc levels in the ovarian follicular fluid of infertile women with endometriosis were lower, compared to tubal infertility (27). The study also indicated that zinc levels in follicular fluid were higher in women with endometriosis who conceived after in vitro fertilization (IVF).
Although there are no studies on supplementation of zinc and its effects on women with endometriosis to our best knowledge, researchers found that dietary intake of zinc in women without endometriosis was higher compared to women with endometriosis (28). There is also no meta-analysis on zinc supplementation in endometriosis.
Magnesium
Magnesium is one of the most abundant electrolytes in the human body and is well known to be implied in several important functions such as protein and deoxyribonucleic acid (DNA) synthesis, enzyme activity, and neuromuscular excitability. Approximately 99% of the total body magnesium is stored intracellular, predominantly in muscles, bones, and soft tissues (29). Food sources of magnesium include nuts, grains, spinach, legumes, avacado, and potatoes (30).
Magnesium has been used in gynecological practice for ages. Magnesium deficiency was seen in premenstrual syndrome (31). Mathias et al. (32) observed that the fallopian tubes of women with endometriosis contract irregularly and more spasmodically. Magnesium also relaxes smooth muscles (33) and as a result, may affect retrograde menstruation, thought to be the major cause of endometriosis. As a result of these findings, a decreased risk of endometriosis with increasing magnesium intake can be discussed, with the strong association being with oral magnesium intake by food (18).
Hosgorler et al, studied changes of vascular endothelial growth factor (VEGF) in uterine tissue based on magnesium supplementation in an animal model, found that VEGF decreases after magnesium use, therefore concluding it might be useful in gynecologic diseases that have angiogenesis in their pathophysiological process, like endometriosis (34). Human studies on complimentary use of magnesium in endometriosis are rare, indicates a subject to address in future studies.
Omega-3
Polyunsaturated fatty acids (PUFAs) are rich in omega-3 fatty acids (FAs). In recent years, antiproliferative, antiangiogenic, anti-inflammatory, anti-apoptotic effects of omega-3 PUFAs have been demonstrated in several studies (35).
An association between decreased circulating inflammatory cytokines and dietary PUFA intake was first reported by Pischon and colleagues in 2003 (36). Arachidonic acid (AA) is an omega-6 polyunsaturated fatty acid (PUFA) that is synthesized from linoleic acid, found in plant-derived oils. It is a substrate used for the synthesis of prostaglandins (PGE2) and leukotrienes (LTB4), which are thought related to pelvic pain in endometriosis. On the other hand, eicosapentaenoic acid (EPA) is an omega-3 PUFA, found in fish oil, also serves as a substrate for PGE3 and LTB5 production. PGE3 and LTB5 have less potent inflammatory activity in comparison with those synthesized from AA. Also, EPA inhibits the conversion of AA to PGE2 and LTB4 (37). As a result, omega-3 PUFAs, such as EPA and docosahexaenoic acid (DHA) might inhibit inflammation (38). The anti-inflammatory effect of omega-3 PUFA has been proven by studies showing improvement after dietary intake, on diseases like atherosclerosis, rheumatoid arthritis, and asthma (39).
PUFAs are probably the most extensively studied supplement on endometriosis pathogenesis, symptoms, and outcomes. An in vitro study by Gazvani et al have shown that survival of endometrial cells from women with and without endometriosis was significantly reduced in the presence of high omega-3:omega-6 PUFA ratios compared with cells incubated in the absence of fatty acids, in balanced omega-3:omega-6 PUFA ratios, and in high omega-6:omega-3 PUFA ratios (40). Animal studies have reported decreased endometriosis-associated pain after omega 3 supplementation (41). Besides symptom relief, PUFAs have a role in preventing disease pathogenesis (42). Also, adding fish oils to the diet of endometriosis models, decreased the size of the lesions caused by endometriosis (43,44).
Human studies vary between food frequency questionnaires and supplementation trials. A cohort of endometriosis patients was given various supplements including omega 3, and visual analog scale (VAS) scores were improved compared to controls (45). Fish oil supplemented adolescents with endometriosis were reported to have a 50% drop in VAS scores (46). Women with higher circulating levels of EPA are less likely to have endometriosis (47). Reviews have reported similar results, underlining the heterogeneity and generally experimental nature of studies (48,49).
Propolis
Propolis has a long history of use due to its therapeutic characteristics. In experimental medicine, it was used to treat malignant tumors, local wounds, and ulcers. Propolis compounds include terpenes, flavonoids, phenolic acids as well as sugar, protein, vitamins, and abundant minerals. Flavonoids have an extensive range of biological behavior, including anti-inflammatory, anti-oxidant, anti-bacterial, and anti-viral properties (50).
Chrysin is a natural flavonoid mainly found in plant extracts, propolis, and honey. In vitro studies have shown that chrysin stimulates an increase in apoptosis and a decrease in proliferation in human endometriotic cells; to suppress the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway related to the proliferation of endometriotic cells (51). To our best knowledge, there are no animal or human studies on the effects of propolis in endometriosis.
Curcumin
Curcumin is the principal polyphenol isolated from turmeric. Anti-inflammatory, anti-metastatic, the anti-oxidant, wound healing, hypoglycemic, anti-angiogenic, anti-microbial, antitumor, anti-mutagenic, and hormonal regulatory properties of curcumin were reported by numerous in vitro and vivo studies (52-54).
Curcumin seemed to improve folliculogenesis in endometriosis, reported an in vitro study (55). Moreover, curcumin leads to reduced estrogen production, thus inhibits endometriosis development (56). An in vivo study on mouse models designed a curcumin delivery system to the peritoneum, and showed a reduction in endometrial glands and stroma, along with the significant decrease of infiltrating inflammatory cells (57). Many animal studies reported decreased endometriotic implant size or delayed development after curcumin supplementation (58-60). Treatment with curcumin reduces inflammation by decreasing the expression of pro-inflammatory cytokines, also inhibits invasion, attachment, and angiogenesis of endometrial lesions (56,61).
Human studies investigating the effect of curcumin supplementation reported downregulation of vascular endothelial growth factor (VEGF) signaling pathway and decreased serum CA 125 and PGE2 levels (45,62). Thus, it may have potential benefits as a dietary supplement and pharmacological agent for prevention and as part of the treatment of endometriosis (63).
Quercetin
Quercetin (3,3′,4′,5,7-pentahydroxyflavone) is a major dietary flavonol found in vegetables and fruits such as onion, cauliflower, lettuce, apple skin, and chili pepper. Quercetin inhibits proliferation and induces cell cycle arrest in endometriotic cells. Furthermore, it has been shown to induce apoptosis by causing the production of reactive oxygen species, DNA fragmentation, loss of mitochondrial membrane potential, with in vitro and in vivo studies (64). In an animal study, it was also shown that it has anti-estrogenic and progestogenic effects (65). Hence, quercetin may have a potential role as a natural therapy to improve and treat endometriosis.
N-acetylcysteine
N-acetylcysteine (NAC), is the acetylated form of the amino acid cysteine. It is naturally present in some vegetables like onion and garlic and shows a marked antiproliferative action in vitro on cancer cells of epithelial origin—also the origin of endometrial cells (66). In vitro studies showed that NAC action neither involves induction of cell death nor is due to a specific toxic effect; rather, it builds a differentiation pathway, including activation of specific molecular mechanisms all converge into proliferation switch, eventually causing decreased cell proliferation and a decrease in cell locomotory behavior, especially relevant in endometriosis (67). In addition, NAC downregulates inflammatory protein activity (67).
Animal studies have shown that NAC causes significant decreases in mean lesion areas, in serum and peritoneal TNF-alpha levels, in levels of inflammatory cyclooxygenase (COX) -2 enzyme; this could be a possible explanation of the observed reduction in dimensions of endometrioma (68,69). Indeed, decreasing COX-2 expression reduces available estrogen in ectopic endometrial tissue through decreased production of PGE2—a powerful stimulator of aromatase. Considering NAC action on cell signaling and protein activity, overall causing a deranged proliferation, researchers reported reduced endometrioma size on NAC supplemented women and argued it can effectively help the medical treatment of ovarian endometriosis and prevent recurrence (70). Also combined effect of NAC, alpha-lipoic acid, and bromelain significantly decreased pain in endometriotic women (70).
Probiotics
Probiotics, prebiotics, or synbiotics in the diet are favorable for the intestinal microbiota. These may be consumed in the form of dairy products, raw vegetables, and fruits. Another source may be pharmaceutical formulas and functional food (71). One of the major positive effects of probiotics on human health is improved immunity (72). In 2007, the World Health Organisation (WHO) experts described prebiotics as a nonviable food component that is beneficial when consumed, by modulation of the microbiota (73).
Probiotic microorganisms such as Lactobacillus Plantarum, Lactobacillus reuteri, Bifidobacterium adolescentis and Bifidobacterium pseudocatenulatum are natural producers of vitamin B (71). Particularly in patients suffering from endometriosis, probiotics are important in this respect, because vitamin B levels are usually lower than the normal population. They also increase the efficiency of the immune system, enhance the absorption of vitamins and minerals, and stimulate the synthesis of organic acids and amino acids. Probiotic microorganisms may also be able to produce certain types of enzymes, such as esterase, lipase, and co-enzymes A, Q, NAD, and NADP (71).
Prebiotic use is beneficial in patients with endometriosis, especially in patients with advanced-stage endometriosis, because of the common dysbiosis (72).
Resveratrol
Resveratrol has high levels in foods such as grapes, wine, strawberries, Itadori tea, nuts; and is a natural phytoalexin(trans-3,5,40-trihydroxystilbene) synthesized by plants under the influence of ultraviolet radiation and fungal infections (74,75). There are many studies showing that resveratrol has antineoplastic, anti-inflammatory, antioxidant, antiatherogenic, and antiangiogenic effects (75,76). It is known that the presence of a chronic inflammatory process affects the development of endometriosis (77). Many studies have been conducted on the effect of resveratrol on endometriosis disease, which is known to have antioxidant, anti-inflammatory, and antiangiogenic effects in patients with endometriosis.
In an in vitro study by Taguchi et al, resveratrol has been shown to induce apoptosis by increasing TNF-α-related-apoptosis-inducing ligand (TRAIL) in endometriotic stromal cells (78). In a study on animal models, resveratrol has been shown to reduce, matrix metalloproteinase (MMP)-2 and MMP-9 in patients with endometriosis, and in another study, it has been shown to have anti-inflammatory and antiangiogenic activity, in addition to decreasing vascular endothelial growth factor (VEGF) levels in addition to MMP-2 and MMP-9 (79,80). In an experimental endometriosis model made by Cenksoy et al, the anti-angiogenic and anti-inflammatory effect of resveratrol was reported by showing decreased serum VEGF and MCP1 levels and VEGF staining in endometriotic implants (81). In another experimental model of endometriosis, resveratrol has been shown to reduce micro vascularization and cell proliferation by reducing CD 31 positive endometrial cells in endometriotic tissue (82). In contrast, a randomized controlled trial has failed to show resveratrol’s superiority in women with pain due to endometriosis (83).
Based on its proapoptotic, anti-inflammatory, antioxidant, and antiangiogenic effects, resveratrol may be a complementary treatment to medical therapy in patients with endometriosis.
Alpha Lipoic Acid
Alpha-lipoic acid (α-LA) is a substance naturally found in spinach, broccoli, and tomatoes, and is also synthesized in the human body. It has two isoforms: oxidized lipoic acid and reduced dihydrolipoic acid. α-LA is both hydrophilic and lipophilic. When taken orally, it is absorbed from intestinal villi and reduced to dihydrolipoic acid (DHLA) in hepatocytes. It is a high reductant, a powerful antioxidant. In a study based on the anti-inflammatory and antioxidant effect of α-LA in an experimental endometriosis model, the oxidant status and oxidative stress index, endometrial implant volumes, and histopathological scores were shown to be lower in the study group compared to the control group (84). Other in vivo studies have shown that regular use of α-LA causes a significant improvement in pain symptoms associated with endometriosis such as dyspareunia, dysmenorrhea, and chronic pelvic pain, as well as decreased quality of life and sexual functions (70,85,86).
In addition to medical treatment, the use of α-LA may be a suitable option to decrease symptoms and improve the quality of life, especially in patients predominantly presenting with pain.
Vitamin C
Vitamin C is a water-soluble vitamin that is naturally present in citrus fruits, tomatoes, potatoes, red and green peppers, kiwi, broccoli, and strawberries. Humans, unlike most animals, are unable to synthesize vitamin C endogenously, so it is an essential dietary component.
Formulated as two phenolic hydroxyl groups containing 2-3 endiol-L gluconic acid lactone, vitamin C is a powerful reductive and is one of the most important antioxidants in the human body (87). Antioxidants inhibit lipid peroxidation by inhibiting the peroxidation chain reaction or by deactivating reactive oxygen species (88,89). It has been argued that intravenous vitamin C treatment may facilitate the prevention of endometriotic implant induction and regression of endometriotic implant volumes, and this was explained by anti-inflammatory and antiangiogenic effects of vitamin C. Vitamin C supplementation was also found to significantly reduce the volume and weight of endometriotic cysts in a dose-dependent manner (90). In an experimental model by Erten et al., endometriotic implant volumes of the group receiving vitamin C were observed to be significantly smaller than the control group (91). Another animal study had reported significantly reduced endometriotic cyst volumes in vitamin C supplemented models in a dose-dependent manner (90). While human studies are rare on the effects of vitamin C on endometriosis, a randomized controlled trial showed that vitamin C supplementation increased vitamin C levels in follicular fluid, however, had no effect on oxidative stress markers (92).
Vitamin C supplementation can be considered due to its anti-inflammatory and antiangiogenic effects in addition to medical treatment to prevent the growth of endometriotic implants, especially to patients with high oxidative stress.
Vitamin E
Vitamin E, which is found in plant-based oils, nuts, seeds, fruits, and vegetables, consists of tocopherols and tocotrienols. Cell membranes and plasma lipoproteins contain alpha-tocopherol. After oral intake, vitamin E is absorbed via intestinal villi and transported to the liver by chylomicrons. Alpha tocopherols bind to specific proteins and transferred to the circulation. Alpha-tocopherol (vitamin E) inhibits lipid peroxidation and inhibits oxidative stress (93). In vivo studies reported vitamin E levels were lower in patients with endometriosis (94,95). Patients with endometriosis seem to have higher lipid peroxidase and lower selenium, superoxide dismutase, and vitamin E levels compared to healthy controls (96). Vitamin E and glutathione levels were lower in patients with moderate-to-severe endometriosis compared to patients with minimal to mild endometriosis; therefore the reduction of the antioxidant system may be one of the underlying mechanisms and correlate with the severity of the disease (97).
Santanam N et al., found a significant reduction in chronic pelvic pain, dysmenorrhea, dyspareunia, and inflammatory markers in peritoneal fluid (IL-6, MCP- 1) in patients with endometriosis who received antioxidant therapy with combined vitamin C (98). In another study, after six-month therapy with combined vitamin C and E, malondialdehyde (MDA) and lipid hydroperoxides (LOOHs) levels were found to be significantly lower as an indicator of oxidative stress in plasma and peritoneal fluid (99).
Vitamin E has an antioxidant effect, especially on lipid peroxidation. For patients with severe endometriosis and associated infertility, supplementation might be useful as a complementary treatment. However, it may be more appropriate to use combined vitamin E and vitamin C supplements for pain management.
Selenium
Selenium is an essential trace element with nutritional and pharmacological properties (100). Whole grains and dairy products, some fruits and vegetables, white and red meat, seafood, and eggs are good sources of selenium.
In vitro and in vivo studies show that selenium modulates the functions of many regulatory proteins in signal transduction, conferring benefits in inflammatory diseases (101). Decreased selenium levels have been noted in acute and chronic inflammatory states. In a study conducted on patients with endometriosis, when vitamin E, C, selenium, and zinc were given simultaneously, there was an inverse correlation with the intensity of the disease. With the less oral intake of antioxidant nutrients, the more severe disease was observed. There seems to be a positive association between pathological development and lipoperoxidation status (102).
Epigallocatechin-3-gallate (EGCG)
EGCG is a plant-based compound, especially found in green tea. EGCG was found to suppress estrogen-related activation, proliferation, and VEGF expression of endometrial cells in vitro (103,104). It also significantly reduced the mean number and the volume of endometriotic implants, inhibited cell proliferation, reduced vascularization, and increased apoptosis (105). Prevention of fibrosis was another finding of in vitro studies (106).
An in vivo study conducted on mice endometriosis models showed that EGCG significantly decreased the growth of endometrial implants, decreased the lesion size and weight, inhibited angiogenesis, and caused lesion apoptosis (107). Another animal study reported EGCG leads to downregulation of VEGF signaling pathway and decreased VEGF expression, thereby inhibiting angiogenesis in endometriotic implants (108). There are no human studies about EGCG effects on endometriosis.
Conclusion
As in many diseases and conditions, the positive effects of dietary supplements have been shown in endometriosis. Certain types of supplements can be given as a complementary treatment for symptoms, and some are beneficial in preventing the disease.
After a careful review of the literature, we can confidently report that lower levels of vitamin D, zinc, and vitamin E, carry a greater risk for endometriosis. Magnesium, curcumin, resveratrol, and ECGC were beneficial in animal studies due to their antiangiogenic effects. Omega 3 and alpha-lipoic acid improved endometriosis-associated pain in human studies. Curcumin, omega 3, NAC, vitamin C, and ECGC supplementation decreased endometriotic lesion size in animal and human studies. Curcumin, omega 3, and NAC were found to prevent disease pathogenesis or recurrence in animal studies. Conducted studies are summarized in Table 1.
Table 1.
Supplement | In vitro study | Animal study | Human study |
---|---|---|---|
Vitamin D | + | + | + |
Zinc | - | - | + |
Magnesium | + | + | - |
Omega 3 | + | + | + |
Propolis | + | - | - |
Curcumin | + | + | + |
Quercetin | + | + | - |
N-acetylcysteine | + | + | + |
Probiotics | - | - | + |
Resveratrol | + | + | + |
Alpha Lipoic Acid | - | + | + |
Vitamin C | + | + | + |
Vitamin E | + | + | + |
Selenium | + | + | + |
Epigallocatechin-3-gallate | + | + | - |
It is important to note that studies on this issue often have limitations, such as low sample size and experimental study design. Moreover, one should keep in mind that food resources and pharmacological formulas of supplements may have different mechanisms of actions, also there is not a consensus on dosing and recommendation guidelines. However, as more clinicians become aware of the beneficial effects of supplements in dealing with endometriosis, more studies on supplement use concomitant with surgery or medical treatment will follow, and therefore treatment, surveillance, and counseling of patients may improve.
Ethics Approval:
Due to the nature of our study, Ethics approval was not required.
Conflicts of interest:
Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article.
References
- Zondervan KT, Becker CM, Koga K, et al. Endometriosis. Nat Rev Dis Primers. 2018 Jul 19;4(1):9. doi: 10.1038/s41572-018-0008-5. [DOI] [PubMed] [Google Scholar]
- Laganà Antonio Simone, et al. Stem cell trafficking during endometriosis: may epigenetics play a pivotal role? Reprod Sci. 2018;25(7):978–979. doi: 10.1177/1933719116687661. [DOI] [PubMed] [Google Scholar]
- Laganà , Antonio Simone, et al. Unus pro omnibus, omnes pro uno: a novel, evidence-based, unifying theory for the pathogenesis of endometriosis. Medical Hypotheses. 2017;103:10–20. doi: 10.1016/j.mehy.2017.03.032. [DOI] [PubMed] [Google Scholar]
- Lagana Antonio Simone, et al. Evaluation of M1 and M2 macrophages in ovarian endometriomas from women affected by endometriosis at different stages of the disease. Gynecol Endocrinol. 2020;36(5):441–444. doi: 10.1080/09513590.2019.1683821. [DOI] [PubMed] [Google Scholar]
- Laganà , Antonio Simone, et al. The pathogenesis of endometriosis: molecular and cell biology insights. Int J Mol Sci. 2019;20(22):5615. doi: 10.3390/ijms20225615. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Johnson NP, Hummelshoj L, Consortium ftWESM, et al. Consensus on current management of endometriosis. Hum Reprod. 2013;28(6):1552–1568. doi: 10.1093/humrep/det050. [DOI] [PubMed] [Google Scholar]
- Holt VL, Weiss NS. Recommendations for the design of epidemiologic studies of endometriosis. Epidemiology. 2000 Nov;11(6):654–9. doi: 10.1097/00001648-200011000-00007. [DOI] [PubMed] [Google Scholar]
- Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020 Mar 26;382(13):1244–1256. doi: 10.1056/NEJMra1810764. [DOI] [PubMed] [Google Scholar]
- Laganà Antonio Simone, et al. Clinical dynamics of Dienogest for the treatment of endometriosis: from bench to bedside. Expert Opin Drug Metab Toxicol. 2017:593–596. doi: 10.1080/17425255.2017.1297421. [DOI] [PubMed] [Google Scholar]
- Sansone Anna, et al. Effects of etonorgestrel implant on quality of life, sexual function, and pelvic pain in women suffering from endometriosis: results from a multicenter, prospective, observational study. Arch Gynecol Obstet. 2018;298(4):731–736. doi: 10.1007/s00404-018-4851-0. [DOI] [PubMed] [Google Scholar]
- Laganà Antonio Simone, et al. Full-thickness excision versus shaving by laparoscopy for intestinal deep infiltrating endometriosis: rationale and potential treatment options. BioMed Research International. 2016 doi: 10.1155/2016/3617179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Raffaelli Ricciarda, et al. Mesenteric vascular and nerve sparing surgery in laparoscopic segmental intestinal resection for deep infiltrating endometriosis. Eur. J. Obstet. Gynecol. 2018;231:214–219. doi: 10.1016/j.ejogrb.2018.10.057. [DOI] [PubMed] [Google Scholar]
- DRI. The National Academy Washington; 2005. Institute of Medicine, Food and Nutrition Board, Dietary Reference Intakes: energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. [Google Scholar]
- Nothnick WB. Treating endometriosis as an autoimmune disease. Fertil Steril. 2001 Aug;76(2):223–31. doi: 10.1016/s0015-0282(01)01878-7. [DOI] [PubMed] [Google Scholar]
- Almassinokiani F, Khodaverdi S, Solaymani-Dodaran M, et al. Effects of Vitamin D on Endometriosis-Related Pain: A Double-Blind Clinical Trial. Med Sci Monit. 2016 Dec 17;22:4960–4966. doi: 10.12659/MSM.901838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sassi F, Tamone C, D’Amelio P. Vitamin D: Nutrient, Hormone, and Immunomodulator. Nutrients. 2018 Nov 3;10(11) doi: 10.3390/nu10111656. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Akyol A, Şimşek M, İlhan R, et al. Efficacies of vitamin D and omega-3 polyunsaturated fatty acids on experimental endometriosis. Taiwan J Obstet Gynecol. 2016 Dec;55(6):835–839. doi: 10.1016/j.tjog.2015.06.018. [DOI] [PubMed] [Google Scholar]
- Harris HR, Chavarro JE, Malspeis S, et al. Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis: a prospective cohort study. Am J Epidemiol. 2013 Mar 1;177(5):420–30. doi: 10.1093/aje/kws247. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Qiu Y, Yuan S, Wang H. Vitamin D status in endometriosis: a systematic review and meta-analysis. Arch Gynecol Obstet. 2020 Jul;302(1):141–152. doi: 10.1007/s00404-020-05576-5. [DOI] [PubMed] [Google Scholar]
- Trumbo P, Yates AA, Schlicker S, et al. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Journal of the Academy of Nutrition and Dietetics. 2001;101(3):294. doi: 10.1016/S0002-8223(01)00078-5. [DOI] [PubMed] [Google Scholar]
- Zaichick S, Zaichick V, Nosenko S, et al. Mass fractions of 52 trace elements and zinc/trace element content ratios in intact human prostates investigated by inductively coupled plasma mass spectrometry. Biol Trace Elem Res. 2012 Nov;149(2):171–83. doi: 10.1007/s12011-012-9427-4. [DOI] [PubMed] [Google Scholar]
- Malavolta M, Piacenza F, Basso A, et al. Speciation of trace elements in human serum by micro anion exchange chromatography coupled with inductively coupled plasma mass spectrometry. Anal Biochem. 2012 Feb 1;421(1):16–25. doi: 10.1016/j.ab.2011.11.004. [DOI] [PubMed] [Google Scholar]
- O’Connor JM. Trace elements and DNA damage. Biochem Soc Trans. 2001 May;(29(Pt 2)):354–7. [PubMed] [Google Scholar]
- Prasad AS. Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care. 2009 Nov;12(6):646–52. doi: 10.1097/MCO.0b013e3283312956. [DOI] [PubMed] [Google Scholar]
- Messalli EM, Schettino MT, Mainini G, et al. The possible role of zinc in the etiopathogenesis of endometriosis. Clin Exp Obstet Gynecol. 2014;41(5):541–6. [PubMed] [Google Scholar]
- Lai GL, Yeh CC, Yeh CY, et al. Decreased zinc and increased lead blood levels are associated with endometriosis in Asian Women. Reprod Toxicol. 2017 Dec;74:77–84. doi: 10.1016/j.reprotox.2017.09.001. [DOI] [PubMed] [Google Scholar]
- Singh AK, Chattopadhyay R, Chakravarty B, et al. Markers of oxidative stress in follicular fluid of women with endometriosis and tubal infertility undergoing IVF. Reprod Toxicol. 2013 Dec;42:116–24. doi: 10.1016/j.reprotox.2013.08.005. [DOI] [PubMed] [Google Scholar]
- Mier-Cabrera J, Aburto-Soto T, Burrola-Méndez S, et al. Women with endometriosis improved their peripheral antioxidant markers after the application of a high antioxidant diet. Reprod Biol Endocrinol. 2009 May 28;7:54. doi: 10.1186/1477-7827-7-54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ayuk J, Gittoes NJ. Contemporary view of the clinical relevance of magnesium homeostasis. Ann Clin Biochem. 2014 Mar;(51(Pt 2)):179–88. doi: 10.1177/0004563213517628. [DOI] [PubMed] [Google Scholar]
- Volpe SL. Magnesium in disease prevention and overall health. Adv Nutr. 2013 May 1;4(3):378s–83s. doi: 10.3945/an.112.003483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sherwood RA, Rocks BF, Stewart A, et al. Magnesium and the premenstrual syndrome. Ann Clin Biochem. 1986 Nov;23 (Pt 6):667–70. doi: 10.1177/000456328602300607. [DOI] [PubMed] [Google Scholar]
- Mathias JR, Franklin R, Quast DC, et al. Relation of endometriosis and neuromuscular disease of the gastrointestinal tract: new insights. Fertil Steril. 1998 Jul;70(1):81–8. doi: 10.1016/s0015-0282(98)00096-x. [DOI] [PubMed] [Google Scholar]
- D’Angelo EK, Singer HA, Rembold CM. Magnesium relaxes arterial smooth muscle by decreasing intracellular Ca2+ without changing intracellular Mg2+ J Clin Invest. 1992 Jun;89(6):1988–94. doi: 10.1172/JCI115807. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hoşgörler F, Kızıldağ S, Ateş M, et al. The Chronic Use of Magnesium Decreases VEGF Levels in the Uterine Tissue in Rats. Biol Trace Elem Res. 2020 Aug;196(2):545–551. doi: 10.1007/s12011-019-01944-8. [DOI] [PubMed] [Google Scholar]
- Spencer L, Mann C, Metcalfe M, et al. The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. Eur J Cancer. 2009 Aug;45(12):2077–86. doi: 10.1016/j.ejca.2009.04.026. [DOI] [PubMed] [Google Scholar]
- Pischon T, Hankinson SE, Hotamisligil GS, et al. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation. 2003 Jul 15;108(2):155–60. doi: 10.1161/01.CIR.0000079224.46084.C2. [DOI] [PubMed] [Google Scholar]
- James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr. 2000 Jan;(71(1 Suppl)):343s–8s. doi: 10.1093/ajcn/71.1.343s. [DOI] [PubMed] [Google Scholar]
- Camuesco D, Gálvez J, Nieto A, et al. Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J Nutr. 2005 Apr;135(4):687–94. doi: 10.1093/jn/135.4.687. [DOI] [PubMed] [Google Scholar]
- Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002 Dec;21(6):495–505. doi: 10.1080/07315724.2002.10719248. [DOI] [PubMed] [Google Scholar]
- Gazvani MR, Smith L, Haggarty P, et al. High omega-3:omega-6 fatty acid ratios in culture medium reduce endometrial-cell survival in combined endometrial gland and stromal cell cultures from women with and without endometriosis. Fertil Steril. 2001 Oct;76(4):717–22. doi: 10.1016/s0015-0282(01)01991-4. [DOI] [PubMed] [Google Scholar]
- Pereira F, Medeiros FDC, Rocha HAL, et al. Effects of omega-6/3 and omega-9/6 nutraceuticals on pain and fertility in peritoneal endometriosis in rats. Acta Cir Bras. 2019 May 6;34(4):e201900405. doi: 10.1590/s0102-865020190040000005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Netsu S, Konno R, Odagiri K, et al. Oral eicosapentaenoic acid supplementation as possible therapy for endometriosis. Fertil Steril. 2008 Oct;90(4 Suppl):1496–502. doi: 10.1016/j.fertnstert.2007.08.014. [DOI] [PubMed] [Google Scholar]
- Tomio K, Kawana K, Taguchi A, et al. Omega-3 polyunsaturated Fatty acids suppress the cystic lesion formation of peritoneal endometriosis in transgenic mouse models. PLoS One. 2013;8(9):e73085. doi: 10.1371/journal.pone.0073085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Covens AL, Christopher P, Casper RF. The effect of dietary supplementation with fish oil fatty acids on surgically induced endometriosis in the rabbit. Fertil Steril. 1988 Apr;49(4):698–703. doi: 10.1016/s0015-0282(16)59842-2. [DOI] [PubMed] [Google Scholar]
- Signorile PG, Viceconte R, Baldi A. Novel dietary supplement association reduces symptoms in endometriosis patients. J Cell Physiol. 2018 Aug;233(8):5920–5925. doi: 10.1002/jcp.26401. [DOI] [PubMed] [Google Scholar]
- Nodler JL, DiVasta AD, Vitonis AF, et al. Supplementation with vitamin D or ω-3 fatty acids in adolescent girls and young women with endometriosis (SAGE): a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2020 May 26 doi: 10.1093/ajcn/nqaa096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hopeman MM, Riley JK, Frolova AI, et al. Serum Polyunsaturated Fatty Acids and Endometriosis. Reprod Sci. 2015 Sep;22(9):1083–7. doi: 10.1177/1933719114565030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parazzini F, Viganò P, Candiani M, et al. Diet and endometriosis risk: a literature review. Reprod Biomed Online. 2013 Apr;26(4):323–36. doi: 10.1016/j.rbmo.2012.12.011. [DOI] [PubMed] [Google Scholar]
- Jurkiewicz-Przondziono J, Lemm M, Kwiatkowska-Pamuła A, et al. Influence of diet on the risk of developing endometriosis. Ginekol Pol. 2017;88(2):96–102. doi: 10.5603/GP.a2017.0017. [DOI] [PubMed] [Google Scholar]
- Gregoris E, Stevanato R. Correlations between polyphenolic composition and antioxidant activity of Venetian propolis. Food Chem Toxicol. 2010 Jan;48(1):76–82. doi: 10.1016/j.fct.2009.09.018. [DOI] [PubMed] [Google Scholar]
- Ryu S, Bazer FW, Lim W, et al. Chrysin leads to cell death in endometriosis by regulation of endoplasmic reticulum stress and cytosolic calcium level. J Cell Physiol. 2019 Mar;234(3):2480–2490. doi: 10.1002/jcp.26770. [DOI] [PubMed] [Google Scholar]
- Chakraborty S, Das K, Saha S, et al. Nuclear matrix protein SMAR1 represses c-Fos-mediated HPV18 E6 transcription through alteration of chromatin histone deacetylation. J Biol Chem. 2014 Oct 17;289(42):29074–85. doi: 10.1074/jbc.M114.564872. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jiménez-Osorio AS, García-Niño WR, González-Reyes S, et al. The Effect of Dietary Supplementation With Curcumin on Redox Status and Nrf2 Activation in Patients With Nondiabetic or Diabetic Proteinuric Chronic Kidney Disease: A Pilot Study. J Ren Nutr. 2016 Jul;26(4):237–44. doi: 10.1053/j.jrn.2016.01.013. [DOI] [PubMed] [Google Scholar]
- Nelson KM, Dahlin JL, Bisson J, et al. The Essential Medicinal Chemistry of Curcumin. J Med Chem. 2017 Mar 9;60(5):1620–1637. doi: 10.1021/acs.jmedchem.6b00975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hendarto H, Yohanes Ardianta Widyanugraha M, Widjiati W. Curcumin improves growth factors expression of bovine cumulus-oocyte complexes cultured in peritoneal fluid of women with endometriosis. Int J Reprod Biomed (Yazd) 2018 Dec;16(12) doi: 10.18502/ijrm.v16i12.3683. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang Y, Cao H, Yu Z, et al. Curcumin inhibits endometriosis endometrial cells by reducing estradiol production. Iran J Reprod Med. 2013 May;11(5):415–22. [PMC free article] [PubMed] [Google Scholar]
- Boroumand S, Hosseini S, Pashandi Z, et al. Curcumin-loaded nanofibers for targeting endometriosis in the peritoneum of a mouse model. J Mater Sci Mater Med. 2019 Dec 14;31(1):8. doi: 10.1007/s10856-019-6337-4. [DOI] [PubMed] [Google Scholar]
- Kizilay G, Uz YH, Seren G, et al. In vivo effects of curcumin and deferoxamine in experimental endometriosis. Adv Clin Exp Med. 2017 Mar-Apr;26(2):207–213. doi: 10.17219/acem/31186. [DOI] [PubMed] [Google Scholar]
- Jelodar G, Azimifar A. Evaluation of serum cancer antigen 125, resistin, leptin, homocysteine, and total antioxidant capacity in rat model of endometriosis treated with Curcumin. Physiol Rep. 2019 Feb;7(4):e14016. doi: 10.14814/phy2.14016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jana S, Chakravarty B, Chaudhury K. Letrozole and curcumin loaded-PLGA nanoparticles: a therapeutic strategy for endometriosis. J Nanomed Biotherap Discov. 2014;4(123) 10.4172. [Google Scholar]
- Zhang Y, Cao H, Hu YY, et al. Inhibitory effect of curcumin on angiogenesis in ectopic endometrium of rats with experimental endometriosis. Int J Mol Med. 2011 Jan;27(1):87–94. doi: 10.3892/ijmm.2010.552. [DOI] [PubMed] [Google Scholar]
- Cao H, Wei YX, Zhou Q, et al. Inhibitory effect of curcumin in human endometriosis endometrial cells via downregulation of vascular endothelial growth factor. Mol Med Rep. 2017 Oct;16(4):5611–5617. doi: 10.3892/mmr.2017.7250. [DOI] [PubMed] [Google Scholar]
- Vallée A, Lecarpentier Y. Curcumin and Endometriosis. International Journal of Molecular Sciences. 2020;21(7):2440. doi: 10.3390/ijms21072440. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Park S, Lim W, Bazer FW, et al. Quercetin inhibits proliferation of endometriosis regulating cyclin D1 and its target microRNAs in vitro and in vivo. The Journal of nutritional biochemistry. 2019;63:87–100. doi: 10.1016/j.jnutbio.2018.09.024. [DOI] [PubMed] [Google Scholar]
- Cao Y, Zhuang M-F, Yang Y, et al. Preliminary study of quercetin affecting the hypothalamic-pituitary-gonadal axis on rat endometriosis model. Evidence-Based Complementary and Alternative Medicine. 2014;2014 doi: 10.1155/2014/781684. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Porpora MG, Brunelli R, Costa G, et al. A promise in the treatment of endometriosis: an observational cohort study on ovarian endometrioma reduction by N-acetylcysteine. Evidence-based Complementary and Alternative Medicine. 2013;2013 doi: 10.1155/2013/240702. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pittaluga E, Costa G, Krasnowska E, et al. More than antioxidant: N-acetyl-L-cysteine in a murine model of endometriosis. Fertility and sterility. 2010;94(7):2905–2908. doi: 10.1016/j.fertnstert.2010.06.038. [DOI] [PubMed] [Google Scholar]
- Onalan G, Gulumser C, Mulayim B, et al. Effects of amifostine on endometriosis, comparison with N-acetyl cysteine, and leuprolide as a new treatment alternative: a randomized controlled trial. Archives of gynecology and obstetrics. 2014;289(1):193–200. doi: 10.1007/s00404-013-2963-0. [DOI] [PubMed] [Google Scholar]
- Agostinis C, Zorzet S, De Leo R, et al. The combination of N-acetyl cysteine, alpha-lipoic acid, and bromelain shows high anti-inflammatory properties in novel in vivo and in vitro models of endometriosis. Mediators Inflamm. 2015;2015:918089. doi: 10.1155/2015/918089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lete I, Mendoza N, de la Viuda E, et al. Effectiveness of an antioxidant preparation with N-acetyl cysteine, alpha lipoic acid and bromelain in the treatment of endometriosis-associated pelvic pain: LEAP study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2018;228:221–224. doi: 10.1016/j.ejogrb.2018.07.002. [DOI] [PubMed] [Google Scholar]
- Markowiak P, Śliżewska K. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients. 2017;9(9):1021. doi: 10.3390/nu9091021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ata B, Yildiz S, Turkgeldi E, et al. The endobiota study: comparison of vaginal, cervical and gut microbiota between women with stage 3/4 endometriosis and healthy controls. Scientific reports. 2019;9(1):1–9. doi: 10.1038/s41598-019-39700-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Molina NM, Sola-Leyva A, Saez-Lara MJ, et al. New Opportunities for Endometrial Health by Modifying Uterine Microbial Composition: Present or Future? Biomolecules. 2020;10(4):593. doi: 10.3390/biom10040593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rauf A, Imran M, Butt MS, et al. Resveratrol as an anti-cancer agent: A review. Critical reviews in food science and nutrition. 2018;58(9):1428–1447. doi: 10.1080/10408398.2016.1263597. [DOI] [PubMed] [Google Scholar]
- Nakata R, Takahashi S, Inoue H. Recent advances in the study on resveratrol. Biological and Pharmaceutical Bulletin. 2012;35(3):273–279. doi: 10.1248/bpb.35.273. [DOI] [PubMed] [Google Scholar]
- Chu M, Almagro L, Chen B, et al. Recent trends and comprehensive appraisal for the biotechnological production of trans-resveratrol and its derivatives. Phytochemistry Reviews. 2018;17(3):491–508. [Google Scholar]
- Lousse J-C, Van Langendonckt A, Defrere S, et al. Peritoneal endometriosis is an inflammatory disease. Front Biosci (Elite Ed) 2012;4(1):23–40. doi: 10.2741/e358. [DOI] [PubMed] [Google Scholar]
- Taguchi A, Koga K, Kawana K, et al. Resveratrol enhances apoptosis in endometriotic stromal cells. American Journal of Reproductive Immunology. 2016;75(4):486–492. doi: 10.1111/aji.12489. [DOI] [PubMed] [Google Scholar]
- Tekin YB, Guven S, Kirbas A, et al. Is resveratrol a potential substitute for leuprolide acetate in experimental endometriosis? European Journal of Obstetrics & Gynecology and Reproductive Biology. 2015;184:1–6. doi: 10.1016/j.ejogrb.2014.10.041. [DOI] [PubMed] [Google Scholar]
- Kodarahmian M, Amidi F, Moini A, et al. The modulating effects of Resveratrol on the expression of MMP-2 and MMP-9 in endometriosis women: a randomized exploratory trial. Gynecological Endocrinology. 2019;35(8):719–726. doi: 10.1080/09513590.2019.1576612. [DOI] [PubMed] [Google Scholar]
- Ozcan Cenksoy P, Oktem M, Erdem O, et al. A potential novel treatment strategy: inhibition of angiogenesis and inflammation by resveratrol for regression of endometriosis in an experimental rat model. Gynecological Endocrinology. 2015;31(3):219–224. doi: 10.3109/09513590.2014.976197. [DOI] [PubMed] [Google Scholar]
- Rudzitis-Auth J, Menger M, Laschke M. Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis. Human reproduction. 2013;28(5):1339–1347. doi: 10.1093/humrep/det031. [DOI] [PubMed] [Google Scholar]
- Mendes da Silva D, Gross LA, Neto EdPG, et al. The use of resveratrol as an adjuvant treatment of pain in endometriosis: a randomized clinical trial. Journal of the Endocrine Society. 2017;1(4):359–369. doi: 10.1210/js.2017-00053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pınar N, Soylu Karapınar O, Özcan O, et al. Effect of alpha-lipoic acid on endometrial implants in an experimental rat model. Fundamental & clinical pharmacology. 2017;31(5):506–512. doi: 10.1111/fcp.12293. [DOI] [PubMed] [Google Scholar]
- De VL, Cagnacci A, Cappelli V, et al. Role of a natural integrator based on lipoic acid, palmitoiletanolamide and myrrh in the treatment of chronic pelvic pain and endometriosis. Minerva ginecologica. 2019;71(3):191–195. doi: 10.23736/S0026-4784.19.04384-3. [DOI] [PubMed] [Google Scholar]
- Caruso S, Iraci MS, Casella E, et al. Chronic pelvic pain, quality of life and sexual health of women treated with palmitoylethanolamide and α-lipoic acid. Minerva ginecologica. 2015;67(5):413–419. [PubMed] [Google Scholar]
- Sinclair A, Barnett A, Lunec J. Free radicals and antioxidant systems in health and disease. British journal of hospital medicine. 1990;43(5):334–344. [PubMed] [Google Scholar]
- Brattin WJ, Glende Jr EA, Recknagel RO. Pathological mechanisms in carbon tetrachloride hepatotoxicity. Journal of free radicals in biology & medicine. 1985;1(1):27–38. doi: 10.1016/0748-5514(85)90026-1. [DOI] [PubMed] [Google Scholar]
- Thomas MJ. The role of free radicals and antioxidants: how do we know that they are working? Critical Reviews in Food Science & Nutrition. 1995;35(1-2):21–39. doi: 10.1080/10408399509527683. [DOI] [PubMed] [Google Scholar]
- Durak Y, Kokcu A, Kefeli M, et al. Effect of vitamin C on the growth of experimentally induced endometriotic cysts. Journal of Obstetrics and Gynaecology Research. 2013;39(7):1253–1258. doi: 10.1111/jog.12050. [DOI] [PubMed] [Google Scholar]
- Erten OU, Ensari TA, Dilbaz B, et al. Vitamin C is effective for the prevention and regression of endometriotic implants in an experimentally induced rat model of endometriosis. Taiwanese Journal of Obstetrics and Gynecology. 2016;55(2):251–257. doi: 10.1016/j.tjog.2015.07.004. [DOI] [PubMed] [Google Scholar]
- Lu X, Wu Z, Wang M, et al. Effects of vitamin C on the outcome of in vitro fertilization-embryo transfer in endometriosis: A randomized controlled study. J Int Med Res. 2018 Nov;46(11):4624–4633. doi: 10.1177/0300060518786918. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yao T, Degli Esposti S, Huang L, et al. Inhibition of carbon tetrachloride-induced liver injury by liposomes containing vitamin E. American Journal of Physiology-Gastrointestinal and Liver Physiology. 1994;267(3):G476–G484. doi: 10.1152/ajpgi.1994.267.3.G476. [DOI] [PubMed] [Google Scholar]
- Murphy AA, Santanam N, Morales AJ, et al. Lysophosphatidyl choline, a chemotactic factor for monocytes/T-lymphocytes is elevated in endometriosis. The Journal of Clinical Endocrinology & Metabolism. 1998;83(6):2110–2113. doi: 10.1210/jcem.83.6.4823. [DOI] [PubMed] [Google Scholar]
- Liu F, He L, Liu Y, et al. The expression and role of oxidative stress markers in the serum and follicular fluid of patients with endometriosis. Clin Exp Obstet Gynecol. 2013;40(3):372–376. [PubMed] [Google Scholar]
- Zhao L, Zhao W, Ou Y. Correlation of the metabolism of oxygen free radical in ovary, uterine muscle and vein blood with the pathogenesis of endometriosis or endometrioma. Zhonghua fu chan ke za zhi. 2001;36(5):299–301. [PubMed] [Google Scholar]
- Donabela FC, Andrade A, Rodrigues JK, et al. Serum markers of oxidative stress in infertile women with endometriosis and controls. Fertility and Sterility. 2010;94(4):S40. [Google Scholar]
- Santanam N, Kavtaradze N, Murphy A, et al. Antioxidant supplementation reduces endometriosis-related pelvic pain in humans. Translational Research. 2013;161(3):189–195. doi: 10.1016/j.trsl.2012.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Andrade AZ, Rodrigues JK, Dib LA, et al. Serum markers of oxidative stress in infertile women with endometriosis. Rev Bras Ginecol Obstet. 2010 Jun;32(6):279–85. doi: 10.1590/s0100-72032010000600005. [DOI] [PubMed] [Google Scholar]
- MacFarquhar JK, Broussard DL, Melstrom P, et al. Acute selenium toxicity associated with a dietary supplement. Arch Intern Med. 2010 Feb 8;170(3):256–61. doi: 10.1001/archinternmed.2009.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morgia G, Cimino S, Favilla V, et al. Effects of Serenoa repens, selenium and lycopene (Profluss®) on chronic inflammation associated with benign prostatic hyperplasia: results of “FLOG” (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study. Int Braz J Urol. 2013 Mar-Apr;39(2):214–21. doi: 10.1590/S1677-5538.IBJU.2013.02.10. [DOI] [PubMed] [Google Scholar]
- Hernández Guerrero CA, Bujalil Montenegro L, de la Jara Díaz J, et al. Endometriosis and deficient intake of antioxidants molecules related to peripheral and peritoneal oxidative stress. Ginecol Obstet Mex. 2006 Jan;74(1):20–8. [PubMed] [Google Scholar]
- Laschke MW, Schwender C, Scheuer C, et al. Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo. Hum Reprod. 2008 Oct;23(10):2308–18. doi: 10.1093/humrep/den245. [DOI] [PubMed] [Google Scholar]
- Xu H, Lui WT, Chu CY, et al. Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model. Hum Reprod. 2009 Mar;24(3):608–18. doi: 10.1093/humrep/den417. [DOI] [PubMed] [Google Scholar]
- Ricci AG, Olivares CN, Bilotas MA, et al. Natural therapies assessment for the treatment of endometriosis. Hum Reprod. 2013 Jan;28(1):178–88. doi: 10.1093/humrep/des369. [DOI] [PubMed] [Google Scholar]
- Matsuzaki S, Darcha C. Antifibrotic properties of epigallocatechin-3-gallate in endometriosis. Hum Reprod. 2014 Aug;29(8):1677–87. doi: 10.1093/humrep/deu123. [DOI] [PubMed] [Google Scholar]
- Wang CC, Xu H, Man GC, et al. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice. Angiogenesis. 2013 Jan;16(1):59–69. doi: 10.1007/s10456-012-9299-4. [DOI] [PubMed] [Google Scholar]
- Xu H, Becker CM, Lui WT, et al. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo. Fertil Steril. 2011 Oct;96(4):1021–8. doi: 10.1016/j.fertnstert.2011.07.008. [DOI] [PubMed] [Google Scholar]